Klank, D.; Löffler, C.; Friedrich, J.; Hoffmann, M.; Paschka, P.; Bergner, R.
The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure. Biomedicines 2024, 12, 1032.
https://doi.org/10.3390/biomedicines12051032
AMA Style
Klank D, Löffler C, Friedrich J, Hoffmann M, Paschka P, Bergner R.
The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure. Biomedicines. 2024; 12(5):1032.
https://doi.org/10.3390/biomedicines12051032
Chicago/Turabian Style
Klank, David, Christian Löffler, Julian Friedrich, Martin Hoffmann, Peter Paschka, and Raoul Bergner.
2024. "The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure" Biomedicines 12, no. 5: 1032.
https://doi.org/10.3390/biomedicines12051032
APA Style
Klank, D., Löffler, C., Friedrich, J., Hoffmann, M., Paschka, P., & Bergner, R.
(2024). The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure. Biomedicines, 12(5), 1032.
https://doi.org/10.3390/biomedicines12051032